MCE - Delayed Quote EUR

Euroespes, S.A. (EEP.MC)

0.3400 0.0000 (0.00%)
At close: September 29 at 4:00 PM GMT+2
Loading Chart for EEP.MC
DELL
  • Previous Close 0.3400
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.3400 - 0.3400
  • 52 Week Range 0.3400 - 0.5400
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 3.947M
  • Beta (5Y Monthly) 0.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology. In addition, it researches and develops in the fields of biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The company was founded in 1991 and is based in Corunna, Spain.

www.euroespes.com

39

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: EEP.MC

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EEP.MC
37.04%
IBEX 35...
10.42%

1-Year Return

EEP.MC
37.04%
IBEX 35...
20.07%

3-Year Return

EEP.MC
27.35%
IBEX 35...
29.42%

5-Year Return

EEP.MC
45.60%
IBEX 35...
17.40%

Compare To: EEP.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EEP.MC

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.84

  • Enterprise Value/EBITDA

    -48.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.49%

  • Return on Assets (ttm)

    -5.90%

  • Return on Equity (ttm)

    -16.69%

  • Revenue (ttm)

    3.86M

  • Net Income Avi to Common (ttm)

    -1.14M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    973.75k

  • Total Debt/Equity (mrq)

    71.49%

  • Levered Free Cash Flow (ttm)

    -653.41k

Company Insights: EEP.MC